Early Intraplatelet Signaling Enhances the Release of Human Platelet PAR-1 and -4 Amino-Terminal Peptides in Response to Thrombin
- 30 January 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (7) , 1562-1572
Abstract
Activation of washed human platelets initiated with α-thrombin, SFLLRN, or AYPGKF invariably results in the generation of PAR-1-(1−41) and PAR-4-(1−47). PAR-1-(1−41) and PAR-4-(1−47) are amino-terminal peptides generated when PAR-1 and -4 are cleaved in their first extracellular domains after R41 and R47, respectively, to expose the tethered ligand domains of PAR-1 and -4. Since soybean trypsin inhibitor decreases generation of PAR-1-(1−41) and PAR-4-(1−47) and other platelet aggregation-related responses to these three agonists, but does not inactivate α-thrombin, a platelet trypsin-like proteinase apparently activates PAR-1 and -4 to propagate PAR-dependent platelet responses. This study identified the signaling pathways implicated in the generation of the platelet proteinase that in turn produces PAR-1-(1−41) and PAR-4-(1−47), to thereby drive the subsequent PAR-dependent platelet aggregation-related responses to α-thrombin, SFLLRN, or AYPGKF. Only inhibitors of signaling enzymes that prevented ATP release (forskolin, PGE1, or BIMI-1) prevented or delayed the generation of PAR-1-(1−41) and PAR-4-(1−47) in response to all three agonists. SBTI prevented platelet aggregation initiated by α-thrombin, SFLLRN, or AYPGKF but did so less effectively when it was added 10 s after each agonist. Thus, the platelet-derived proteinase acts within 10 s of each agonist addition to generate PAR-1-(1−41) and PAR-4-(1−47). Furthermore, α-thrombin may not effectively catalyze PAR-1-(1−41) and PAR-4-(1−47) generation. We propose that unidentified ATP-dependent phosphorylation reactions catalyzed by PKC help to generate the platelet-derived proteinase that propagates human platelet PAR-1 and -4 activation by the three agonists.Keywords
This publication has 65 references indexed in Scilit:
- Coordinate Activation of Human Platelet Protease-activated Receptor-1 and -4 in Response to Subnanomolar α-ThrombinJournal of Biological Chemistry, 2008
- Regulation of Protease-Activated Receptor (PAR) 1 and PAR4 Signaling in Human Platelets by Compartmentalized Cyclic Nucleotide ActionsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Clinical Inhibition of the Seven-Transmembrane Thrombin Receptor (PAR1) by Intravenous Aprotinin During Cardiothoracic SurgeryCirculation, 2004
- Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3Biochemical Pharmacology, 2004
- Selective Inhibition of Protease-activated Receptor 4-dependent Platelet Activation by YD-3Thrombosis and Haemostasis, 2002
- The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1The Journal of Thoracic and Cardiovascular Surgery, 2000
- A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activationBiochemical Journal, 1998
- Development of Potent Thrombin Receptor Antagonist PeptidesJournal of Medicinal Chemistry, 1996
- Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionJournal of Medicinal Chemistry, 1993
- Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?Trends in Pharmacological Sciences, 1989